Star Combo Pharma Limited (ASX:S66)

Australia · Delayed Price · Currency is AUD

0.1400

0.00 (0.00%)

Sep 3, 2026, 4:10 PM AEST

Market Cap	18.91M -28.2%
Revenue (ttm)	23.57M -15.2%
Net Income	394.61K -92.5%
EPS	0.00 -90.3%
Shares Out	135.08M
PE Ratio	47.93
Forward PE	n/a
Dividend	0.00 (2.11%)
Ex-Dividend Date	Oct 13, 2026

Volume	25,642
Open	0.1400
Previous Close	0.1400
Day's Range	0.1300 - 0.1400
52-Week Range	0.1100 - 0.2750
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 25, 2026

About Star Combo Pharma

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company engages in the development, manufacturing, marketing, and sale of natural health supplements and skin care products and provision of Chinese health products through its e-commerce platform. It sells its products under the Living Healthy, Costar, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia. [Read more]

Industry Household & Personal Products

Sector Consumer Staples

Founded 2004

Employees 30

Stock Exchange Australian Securities Exchange

Ticker Symbol S66

Full Company Profile

Financial Performance

In fiscal year 2026, Star Combo Pharma's revenue was 23.57 million, a decrease of -15.24% compared to the previous year's 27.81 million. Earnings were 394,606, a decrease of -92.48%.

Financial Statements